| Literature DB >> 23102067 |
Megan L Krause1, Rodrigo Cartin-Ceba, Ulrich Specks, Tobias Peikert.
Abstract
Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.Entities:
Mesh:
Year: 2012 PMID: 23102067 PMCID: PMC3483562 DOI: 10.1016/j.iac.2012.08.001
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479